Medicines Distribution Consent




14 MARCH

NEW ZEALAND GAZETTE 647

Product: Flucloxacillin Oral Solution
Active Ingredient: Flucloxacillin sodium 27.2mg/mL equivalent to 25mg/mL flucloxacillin
Dosage Form: Oral solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Athlone Laboratories Limited, Ballymurray, County Roscommon, Ireland

Product: Flucloxacillin Oral Solution
Active Ingredient: Flucloxacillin sodium 54.4mg/mL equivalent to 50mg/mL flucloxacillin
Dosage Form: Oral solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Athlone Laboratories Limited, Ballymurray, County Roscommon, Ireland

Dated this 6th day of March 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on 20 February 1997).

go1647


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Naropin
Active Ingredient: Ropivacaine hydrochloride (monohydrate) 2.12mg/mL equivalent to 2mg/ml Ropivacaine hydrochloride anhydrous
Dosage Form: Solution for injection
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Södertälje, Sweden
AstraZeneca Pty Limited, North Ryde, New South Wales, Australia
NPBI BV, Runde, Emmer-Compascuum, The Netherlands

Product: Risperdal
Active Ingredient: Risperidone 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Janssen Pharmaceutica NV, Beerse, Belgium

Product: Risperdal
Active Ingredient: Risperidone 0.25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer(s): Janssen Pharmaceutica NV, Beerse, Belgium
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy

Product: Risperdal
Active Ingredient: Risperidone 0.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer(s): Janssen Pharmaceutica NV, Beerse, Belgium
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy

Product: Risperdal
Active Ingredient: Risperidone 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer(s): Janssen Pharmaceutica NV, Beerse, Belgium
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy

Product: Risperdal
Active Ingredient: Risperidone 2mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer(s): Janssen Pharmaceutica NV, Beerse, Belgium
Janssen-Cilag SpA, Borgo San Michele, Latina, Italy



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 23


Gazette.govt.nz PDF NZ Gazette 2002, No 23





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
6 March 2002
Medicines, Distribution, Flucloxacillin, Oral Solution
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines, Distribution, Naropin, Risperdal, Ropivacaine, Risperidone